What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Enterprise Value?

BridgeBio Oncology Therapeutics, Inc. Common Stock's Enterprise Value is $509.5M, based on as-reported figures from SEC (XBRL) filings.

What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Income (TTM)?

BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Income (TTM) is -$182.1M, based on as-reported figures from SEC (XBRL) filings.

What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

BridgeBio Oncology Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.27, based on as-reported figures from SEC (XBRL) filings.

BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) Financial Statements

BridgeBio Oncology Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01L3GYF11

XNAS · usd

9.17▲ 0.31 (3.50%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close8.86

Day's Range8.78 – 9.05

52-Week Range7.00 – 14.87

Volume151.8K

Avg Volume252.5K

Share Statistics

Shares Outstanding

Employees92

ExchangeXNAS

Listed2025-08-12

Share count as of August 6, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Market Cap?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Market Cap is $735.2M, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Enterprise Value?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Enterprise Value is $509.5M, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's EV / EBITDA?: BridgeBio Oncology Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Income (TTM)?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Income (TTM) is -$182.1M, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's EBITDA?: BridgeBio Oncology Therapeutics, Inc. Common Stock's EBITDA is -$198.6M, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.27, based on as-reported figures from SEC (XBRL) filings.
What is BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Debt?: BridgeBio Oncology Therapeutics, Inc. Common Stock's Net Debt is -$225.7M, based on as-reported figures from SEC (XBRL) filings.